Press Releases

Date	Title
03-14-2023	Kura Oncology Announces Acceptance of Two Abstracts for Presentation at AACR Annual Meeting
03-01-2023	Kura Oncology to Participate in Upcoming Investor Conferences
02-23-2023	Kura Oncology Reports Fourth Quarter and Full Year 2022 Financial Results
02-16-2023	Kura Oncology to Report Fourth Quarter and Full Year 2022 Financial Results
02-09-2023	Kura Oncology Announces First Patients Dosed in Phase 2 Registration-Directed Trial of Ziftomenib in NPM1-Mutant Acute Myeloid Leukemia
02-07-2023	Kura Oncology to Participate in SVB Securities Global Biopharma Conference
01-24-2023	Kura Oncology Announces FDA Clearance of IND Application for KO-2806, a Next-Generation Farnesyl Transferase Inhibitor

Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Kura Oncology, Inc.
5510 Morehouse Drive, Suite 110
San Diego, California 92121

Keyword Search